For the Inventor, By the Inventor

Enter assignee name

Bothell, WA, United States of America

Mediquest Therapeutics, Inc.

USPTO Granted Patents = 17

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 170

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Mark R Burns (12 out of 16 patents)

Gerard F Graminski (4 out of 5 patents)

Christine L O'Day (3 out of 6 patents)

4. Donald E Bergstrom (2 out of 16 patents)

5. Maralee McVean (2 out of 7 patents)

6. Thomas P Dooley (2 out of 5 patents)

7. Ernest V Curto (2 out of 3 patents)

8. Frederick J Dechow (2 out of 2 patents)

9. Kevin Kennedy (2 out of 2 patents)

10. Arthur Yeung (2 out of 2 patents)

11. Bruce H Devens (2 out of 2 patents)

12. Nicolaas M J Vermeulin (2 out of 4 patents)

13. Heather K Webb (2 out of 4 patents)

14. Sunil Abraham David (2 out of 13 patents)

15. Nicolaas M J Vermeulen (1 out of 26 patents)

17 patents: Sort by Forward Citations

1. 7858105 - Inhibitors of melanocyte tyrosinase as topical skin lighteners (2010-12-28),

2. 7776349 - Organo-gel formulations for therapeutic applications (2010-08-17),

3. 7740875 - Organo-gel formulations for therapeutic applications (2010-06-22),

4. 7718185 - Inhibitors of melanocyte tyrosinase as topical skin lighteners (2010-05-18),

5. 7432302 - Composition containing polyamine transport inhibitor and use thereof (2008-10-07),

6. 7411002 - Polycationic sulfonamides and use thereof (2008-08-12),

7. 7388112 - Immunomodulation with novel pharmaceutical compositions (2008-06-17),

8. 7232831 - Tetrahydro-β-carboline compounds and use thereof (2007-06-19),

9. 7208528 - Polyamine analogues as therapeutic and diagnostic agents (2007-04-24),

10. 7199267 - Recognition of oligiosaccaride molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases (2007-04-03),

11. 7160923 - Polyamine analogues as therapeutic and diagnostic agents (2007-01-09),

12. 7144920 - Polyamine analogs that activate antizyme frameshifting (2006-12-05),

13. 6963010 - Hydrophobic polyamine analogs and methods for their use (2005-11-08),

14. 6919483 - Immunomodulation with novel pharmaceutical compositions (2005-07-19),

15. 6914079 - Polyamine analogs that activate antizyme frameshifting (2005-07-05),

Mediquest Therapeutics, Inc. is a biotechnology company specializing in the development of innovative therapies for various diseases. With a focus on precision medicine, they leverage cutting-edge research and technology to design targeted treatments that address unmet medical needs. Their team of skilled scientists and clinicians work tirelessly to advance their pipeline of novel drug candidates, with a particular emphasis on oncology and rare genetic disorders. Through collaboration with academic institutions and partnerships with industry leaders, Mediquest Therapeutics aims to bring transformative therapies to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#24 in Bothell, WA

#376 in Washington

#18,331 in US

#34,854 in the World

Bothell, WA, United States of America

Mediquest Therapeutics, Inc.

Forward Citations = 170

19 inventors:

Mark R Burns (12 out of 16 patents)

Gerard F Graminski (4 out of 5 patents)

Christine L O'Day (3 out of 6 patents)

4. Donald E Bergstrom (2 out of 16 patents)

5. Maralee McVean (2 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…